XBiotech Inc (XBIT) — Cash Flow-to-Debt Ratio
XBiotech Inc (XBIT) has a Cash Flow-to-Debt Ratio of -2.36x as of December 2025, meaning its operating cash flow of $-22.95 Million could theoretically repay -2% of its total liabilities ($9.73 Million) in one year. See XBiotech Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
XBiotech Inc Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for XBiotech Inc across 14 annual periods. Also explore XBIT net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for XBiotech Inc (2012–2025)
Year-by-year debt coverage analysis for XBiotech Inc. For market capitalisation and broader financial context, see XBiotech Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -4.10x | $-39.92 Million | $9.73 Million | ▼ -122.9% |
| 2024 | -1.84x | $-30.96 Million | $16.82 Million | ▲ +23.6% |
| 2023 | -2.41x | $-18.73 Million | $7.77 Million | ▲ +7.3% |
| 2022 | -2.60x | $-14.82 Million | $5.70 Million | ▼ -121.7% |
| 2021 | 11.99x | $69.44 Million | $5.79 Million | ▲ +194.0% |
| 2020 | -12.76x | $-65.15 Million | $5.11 Million | ▼ -4178.1% |
| 2019 | -0.30x | $-18.27 Million | $61.25 Million | ▲ +94.7% |
| 2018 | -5.61x | $-16.54 Million | $2.95 Million | ▲ +53.1% |
| 2017 | -11.97x | $-33.65 Million | $2.81 Million | ▼ -107.8% |
| 2016 | -5.76x | $-46.02 Million | $7.99 Million | ▼ -9.1% |
| 2015 | -5.28x | $-33.31 Million | $6.31 Million | ▼ -42.0% |
| 2014 | -3.72x | $-11.70 Million | $3.15 Million | ▲ +64.7% |
| 2013 | -10.54x | $-8.91 Million | $845.00K | ▲ +0.6% |
| 2012 | -10.61x | $-11.63 Million | $1.10 Million | — |